Product
Supplier
Encyclopedia
Inquiry

EN

Home > Chemical News > Pharma News
ECHEMI chemical news

Pharma News

In 2021, the Total Profit of China's Pharmaceutical Industry will Exceed 700 Billion Yuan, a Year-on-year Increase of 67.3%

In 2021, the Total Profit of China's Pharmaceutical Industry will Exceed 700 Billion Yuan, a Year-on-year Increase of 67.3%

On May 10, at the press conference of the National Development and Reform Commission on the "14th Five-Year Plan for Bioeconomic Development"
Johnson & Johnson Ends Partnership With Bavarian Nordic on Hepatitis B and HPV Vaccines

Johnson & Johnson Ends Partnership With Bavarian Nordic on Hepatitis B and HPV Vaccines

On May 9, Johnson & Johnson announced that it had terminated its partnership and licensing agreement with Bavarian Nordic.
The Latest Development of Oral COVID-19 Vaccine May Reduce the Risk of Virus Airborne Transmission

The Latest Development of Oral COVID-19 Vaccine May Reduce the Risk of Virus Airborne Transmission

At present, the vast majority of new crown vaccination methods are intramuscular injection.
Amylyx Announces Latest Statistical Analysis of New ALS Drugs

Amylyx Announces Latest Statistical Analysis of New ALS Drugs

Recently, Amylyx announced the results of the long-term survival analysis of AMX0035 in the treatment of amyotrophic lateral sclerosis (ALS) phase 2 CENTAUR trial adjusted for placebo crossover.
Amylyx ALS drug

2022-05-09

Are More

Are More "Vitamins" in The Feed the Better?

Vitamin, also known as vitamin, is a life-sustaining substance, is a kind of trace organic substances necessary to maintain the normal physiological function and life activities of animals
vitamin feed

2022-05-09

Novartis Suspends Production of Two Radioligand Drugs Due to Potential Quality Issues

Novartis Suspends Production of Two Radioligand Drugs Due to Potential Quality Issues

Novartis announced on Thursday that it has suspended production of neuroendocrine tumor treatment Lutathera and recently FDA-approved prostate cancer treatment Pluvicto at its plants in Ivrea, Italy and Milburn, New Jersey.
Three Months Extension! FDA Delays Pfizer's Myfembree Supplemental New Drug Application

Three Months Extension! FDA Delays Pfizer's Myfembree Supplemental New Drug Application

Just a month ago, the US FDA expressed concern about the supplemental new drug application for the drug Myfembree (relugolix) jointly developed by Pfizer and Myovant Sciences.
FDA Pfizer Myfembree

2022-05-07

FDA Withdraws Accelerated Approval for Bristol-Myers Squibb's PTCL Indication for Romidepsin

FDA Withdraws Accelerated Approval for Bristol-Myers Squibb's PTCL Indication for Romidepsin

On May 6, the U.S. FDA officially announced that it had withdrawn the approval of Bristol-Myers Squibb’s Istodax (romidepsin, romidepsin) for peripheral T-cell lymphoma (PTCL) indications.
FDA Romidepsin

2022-05-07

The Global Pharmaceutical Innovation Index is released!

The Global Pharmaceutical Innovation Index is released!

A few days ago, IDEA Pharma, a British pharmaceutical consulting company, released the 2022 Pharmaceutical Innovation Index and Pharmaceutical Invention Index rankings.
semaglutide dose

2022-05-07

API: Industrial Upgrading, Industrial Extension

API: Industrial Upgrading, Industrial Extension

As always, the 14th Five-Year Plan emphasises the green development of the API industry, pointing out that as the pharmaceutical industry moves towards a new stage of development
API CDMO

2022-05-06

Global Pharmaceutical Innovation: Adhere to Open Development, Win-win Cooperation

Global Pharmaceutical Innovation: Adhere to Open Development, Win-win Cooperation

The "14th Five-Year Plan" emphasizes the adherence to open development, win-win cooperation, and an active response to global pharmaceutical innovation
Suggestions
Email:
Message:
Send Message